Does NATALIZUMAB Cause Atrophy? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Atrophy have been filed in association with NATALIZUMAB (TYRUKO). This represents 0.0% of all adverse event reports for NATALIZUMAB.
17
Reports of Atrophy with NATALIZUMAB
0.0%
of all NATALIZUMAB reports
0
Deaths
9
Hospitalizations
How Dangerous Is Atrophy From NATALIZUMAB?
Of the 17 reports, 9 (52.9%) required hospitalization, and 1 (5.9%) were considered life-threatening.
Is Atrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NATALIZUMAB. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does NATALIZUMAB Cause?
Multiple sclerosis relapse (6,478)
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
What Other Drugs Cause Atrophy?
ADALIMUMAB (76)
ETANERCEPT (43)
METHOTREXATE (37)
TRIAMCINOLONE ACETONIDE (36)
METHYLPREDNISOLONE (34)
INTERFERON BETA-1A (33)
ALENDRONATE (32)
SECUKINUMAB (30)
RITUXIMAB (29)
FINGOLIMOD (28)